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INTRODUCTION
Benzodiazepines are a group of psychoactive drugs 
with anxiolytic (anti-anxiety), sedative, hypnotic, 
anticonvulsant, muscle relaxant and amnesic proper-
ties. These drugs are used in the symptomatic relief 
of anxiety and tension states resulting from a stressful 
environment or emotional factors. They are also use-
ful in psychoneurotic states, panic attacks and alcohol 
withdrawal. Benzodiazepines produce their effects by 
binding to a specific site on the GABAA receptor (gam-
ma-aminobutyric acid, an inhibitory neurotransmitter) 
causing an allosteric change to it. This results in in-
creasing the receptor’s affinity for GABA and leads to 
the depression of the central nervous system1.
Alprazolam (AZ) [8-chloro-1-methyl-6-phenyl-
4H-(1,2,4) triazolo [4,3a] [1,4] benzodiazepine] is 
a short-acting benzodiazepine used to treat moder-
ate to severe anxiety disorders, panic attacks and as 
an adjunctive treatment for anxiety associated with 
moderate depression2. Lorazepam (LZ) [7-chloro-5
-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-ben-
zodiazepine-2-one] is a short-to-medium-acting ben-
zodiazepine, which is principally used in the treatment 
of anxiety and transient situational stress3.
One of the first benzodiazepines, diazepam, was 
found to present mutagenic and genotoxic effects in 
bone marrow cells of mice4 and aneuploidy in cultured 
mammalian cells, mitotic/meiotic arrest, structural 
aberrations and micronuclei in various in vivo and in 
vitro assays5,6. However, the results from in vitro and 
in vivo studies of diazepam effects on human chromo-
somes are conflicting. In previous studies, we showed 
that diazepam is cytogenetically active evaluating the 
Sister Chromatid Exchanges (SCEs) and Proliferation 
Rate Index (PRI) in normal human lymphocyte cul-
tures7. Despite their extended use, cytogenetic effects 
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of both AZ and LZ have not been studied as yet in 
humans. We decided, therefore, to investigate the cy-
totoxic and cytostatic activity of AZ and LZ in normal 
human lymphocyte cultures. In order to determine 
their influence on genetic stability and/or subsequent 
DNA repair (cytotoxic effect), we estimated the fre-
quency of SCEs. The antiproliferative activity (cyto-
static effect) was measured using the PRI values.
The consequences of the exposure to potential mu-
tagens/carcinogens have been commonly studied in 
humans by cytogenetic methods and positive respons-
es should be regarded as indicators of a genotoxic haz-
ard. There are some sensitive biomarkers of genotox-
icity such as chromosomal aberrations, comet assay, 
micronuclei, but SCE frequency has been proved as 
one of the most sensitive indices among them. SCEs 
can provide insight in the cytogenetic damage induced 
by various genotoxic agents at very low concentra-
tions. The determination of PRI in lymphocyte cul-
tures has been proved to be a very useful and sensitive 
indicator of the cytostatic action of various environ-
mental hazards or therapeutic agents8.
MATERIALS AND METHODS
In vitro SCE and PRI assays
Blood from two different healthy donors, 25-35 years 
old, non-smokers, not receiving any drugs, not con-
suming considerable quantities of alcohol or not hav-
ing suffered from any kind of infection for the last 15 
days, was used for two different experiments.
Human lymphocyte cultures were prepared by 
adding in 5ml chromosome medium (RPMI-1640, 
Biochrome, Berlin) at the beginning of culture life, 
the following:
• 11-12 drops of normal human heparinized whole 
blood
• 5μg/ml 5-Bromodeoxyuridine (BrdU) and
• the solutions (final concentrations per culture) of 
AZ (0.16, 0.32, 0.64,1.28, 2.56, 3.84 μΜ) and LZ 
(0.62, 1.24, 1.86, 2.48, 3.1, 3.72 μΜ) 
The concentrations of the drugs used were equiva-
lent to the oral doses9. The cultures were incubated at 
37οC for 72 hours, in the dark to minimize photolysis 
of BrdU. Colchicine (0.3μg/ml) was added 2h before 
the collection of the cultures. The cells were then 
collected by centrifugation and exposed to 0.075 M 
KCl for 10 minutes. The hypotonic solution spreads 
the chromosomes and hemolyses the red blood cells. 
The pellet was fixed three times with methanol:acetic 
acid (3:1). Drops of concentrated suspension of cells 
were placed on microslides that allowed to air dry. For 
SCEs and PRI analysis, the slides were stained by a 
modification of the Fluorescence Plus Giemsa proce-
dure to obtain harlequin chromosomes10.
Statistical analysis
For SCEs more than 20 suitably spread 2nd division 
cells from each culture were blindly scored. For 
PRI at least 100 cells in the 1st, 2nd, 3rd and higher 
divisions from each culture were blindly scored. 
PRI=M1+2M2+3M3+/100, where M1, M2, and M3 are 
the percent values of cells in the 1st, 2nd, 3rd and 
higher divisions respectively. For the statistical evalu-
ation of the experimental data, Student’s t-test was 
performed to determine whether any SCE values dif-
fered significantly from the controls and the X2 test 
was used for the cell kinetic comparison (PRI). Simple 
linear correlation between SCEs and PRI frequencies 
were also calculated using Pearson’s product moment 
correlation coefficient r. Then a criterion for testing 
whether r differs significantly from zero was applied, 
whose sampling distribution is Student’s t test with 
n-2 d.f. 
RESULTS
The oral dosage is for AZ 0.25-6 mg/day and for LZ 
1-6 mg/day. Final concentrations per culture (0.16-
3.84 μΜ for AZ and 0.62-3.72 μΜ for LZ) were equiv-
alent to the oral doses. The results show that both AZ 
and LZ cause a dose-dependent increase of SCE fre-
quency. AZ induced statistically significant (p<0.001) 
increase at all concentrations tested in the two experi-
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Table 1. Cytogenetic activity of AZ in normal human lymphocyte cultures from two different healthy donors.
Equivalent 
oral dosage  
(mg/day)
Concentration 
(μΜ)
Concentration  
(μg/ml culture)
1st donor
SCEs±SE/cell
2nd donor
SCEs±SE/cell
1st donor
PRI
2nd donor
PRI
0 Control 0 7,08±0,503
7,10±
0,38 2,19 2,166
0,25 0,16 0,049 10,070±0,923*
10,767±
0,532* 1,975 2,111
0,5 0,32 0,098 11,201±0,905*
12,604±
0,530* 1,927 2,064
1 0,64 0,196 12,322±0,719*
13,266±
0,487* 1.91 1,973
2 1,28 0,392 12,565±0,808*
15,063±
0,587* 1,801** 1,946**
4 2,56 0,784 12,998±0,854*
16,241±
0,879* 1,79** 1,95**
6 3,84 1,176 13,323±0,714*
15,788±
0,686* 1,77** 1,798**
Table 2. Cytogenetic activity of LZ in normal human lymphocyte cultures from two different healthy donors.
Equivalent 
oral dosage 
(mg/day)
Concentration 
(μΜ/)
Concentration  
(μg/ml culture)
1st donor
SCEs±SE/cell
2nd donor
SCEs±SE/cell
1st donor
PRI
2nd donor
PRI
0 Control 0 9,272±0,458
6,55±
0,716 2,517 2,127
1 0,62 0,199 10,497±0,45
8,12±
0,582 2,44 2,06
2 1,24 0,398 12,433±0,75
9,08±
0,568 2,441 1,98
3 1,86 0,597 13,738±0,675*
11,902±
0,579* 2,366 1,984
4 2,48 0,796 16,759±0,653*
12,277±
0,553* 2,397 1,966
5 3,1 0,995 16,445±0,727*
13,468±
0,567* 2,324 1,955
6 3,72 1,194 18,562±0,676*
14,602±
0,633* 2,240** 1,923**
*Statistically significant (p<0.001) increase over the corresponding control (t-test)
**Statistically significant (p<0.001) decrease over the corresponding control (X² test)
A minimum of 20 cells was scored for SCEs from each culture
SE = standard error of the mean
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ments, though LZ had this effect at the concentrations 
of 1.86 to 3.72 μM in the two experiments. AZ and 
LZ induced a decrease of PRI levels at all concentra-
tions tested, which became statistically significant at 
1.28-3.84 μΜ for AZ and at 3.72 μΜ for LZ in the two 
experiments. In addition, a correlation was observed 
(p < 0.01) between the magnitude of the SCE induc-
tion and the PRI depression (r = -0.94 and t = 6.06 p 
< 0.01 for AZ and r = -0.91 and t = 4.81 p < 0.01 for 
LZ).
The results are given at Table 1 for AZ and Table 
2 for LZ.
DISCUSSION
Among the most interesting adverse reactions of 
drugs are genotoxic and carcinogenic effects. Current 
guidelines for genotoxicity testing of pharmaceuticals 
indicate a standard test battery that consists of: (i) a 
test for gene mutation in bacteria, (ii) an in vitro test 
with cytogenetic evaluation of chromosomal damage 
with mammalian cells or an in vitro mouse lymphoma 
tk assay, (iii) an in vivo test for chromosomal damage 
using rodent haematopoietic cells. Benzodiazepines 
have been extensively used since 1960 for the treat-
ment of anxiety, as hypnotics, sedatives and for other 
conditions. For many of them, more than 50, lack of 
studies do not allow the evaluation of their genotoxic-
carcinogenic potential risk to humans. Diazepam, the 
most extensively tested, gave both positive and nega-
tive results in genotoxicity assays and was carcino-
genic to mice but not to rats, hamsters and gerbils11. 
In a previous series of experiments7, we estimated the 
SCEs and PRI in normal human lymphocyte cultures, 
in order to study the cytotoxic and cytostatic activity 
of diazepam in vitro. The results showed that it causes 
a dose-dependent, statistically significant increase of 
SCE frequency, followed by an equally significant de-
crease of PRI in all four experiments performed.
AZ and LZ are two widely used benzodiazepines, 
which gave negative or equivocal responses in both 
genotoxicity and carcinogenicity assays in S. typhimu-
rium, animal cells in vitro, rat bone-marrow cells and 
rat liver in vivo11. Their effect on DNA strand breaks 
in human cells in vitro hasn’t been tested as yet. Carlo 
P. et al12 found absence of liver DNA fragmentation 
(DNA damage in vivo is considered a sensitive index 
of potential mutagenic-carcinogenic activity) in rats 
treated with high oral doses of 32 benzodiazepines, 
among which were AZ and LZ. Despite that, they sug-
gest that studies performed in different laboratories or 
in different biological systems and consequently the 
use of several assays with different genetic endpoints 
may allow a better approach to the estimation of mu-
tagenic-carcinogenic hazards. 
In our study, both AZ and LZ exhibited dose-
dependent cytogenetic activity in vitro, increasing 
SCE frequencies and diminishing PRI levels in nor-
mal human lymphocyte cultures. The presence of 
the –NHCO- group in LZ’s molecule might be re-
sponsible for its cytotoxic and cytostatic effect. The 
–NHCO- group is thought to interact with similar 
groups or with structure-specific domains in DNA and 
proteins13. AZ has a triazolo-ring, which seems to be 
even more cytotoxic than the lactamic one of LZ and a 
-CH3- group that could be an alkylating group. AZ, in 
oral doses, imposed a stronger cytogenetically effect 
than LZ. We found that AZ is cytotoxic at all doses 
and cytostatic at half of them, whereas LZ exhibited 
cytotoxic activity at the higher doses and cytostatic at 
the highest one.
Benzodiazepines are considered as safe and ef-
fective drugs in short term use, with low toxicity in 
humans, but for many of them published or otherwise 
publicly accessible data do not allow the evaluation 
of genotoxic-carcinogenic risk to humans. Our results 
suggesting that both benzodiazepines are cytogeneti-
cally active (with AZ more effective than LZ on a 
molar basis) are based on in vitro studies. The final 
concentrations of AZ and LZ in the cultures were 
equivalent to oral doses, but they were higher than the 
therapeutic doses because of the pharmacokinetic be-
haviour of the compounds (high protein binding) after 
oral administration. So we intend to extend this very 
interesting research in other cell lines and in vivo ex-
periments too. 
There are findings indicating that the effectiveness 
of SCE induction by potential antitumor agents in 
cancer cells in vitro and in vivo is positively correlat-
ed with in vivo tumour response to these agents14. The 
incidence of SCEs on peripheral human lymphocytes 
in vivo might be an appropriate method for evaluating 
exposure to various agents including chemotherapeu-
tics: peripheral lymphocytes are the dosimeter of such 
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an exposure, since they circulate throughout all tissues 
of the body and a proportion of them are long-lived8. 
The SCE assay has predictive value as a clinical as-
say for drugs for which a strong correlation between 
cell death and induction of SCEs has been established. 
Other studies investigating a relationship between 
SCE induction and other expressions of genotoxic-
ity have also shown a positive relationship between 
SCEs, reduced cell survival and alteration in cell cycle 
kinetics15. Since in the present study a strong correla-
tion (p < 0.01) between SCE enhancement and PRI 
depression was established in lymphocyte cultures 
(in vitro), further studies in experimental tumours (in 
vivo) for evaluating possible antineoplastic potential 
by these chemicals are warranted.
ΠΕΡΙΛΗΨΗ: Η αλπραζολάμη (ΑΖ) και η λοραζεπάμη (ΛΖ) ανήκουν στις βενζοδιαζεπίνες, μια πολυπληθή κατηγορία βιο-
λογικά ενεργών ουσιών. Παρά την ευρεία χρήση ορισμένων εξ αυτών (αγχολυτικά, ηρεμιστικά και αντιεπιληπτικά φάρμακα), 
οι γνώσεις για την κυτταρογενετική τους δράση είναι περιορισμένες. Στην παρούσα μελέτη, εξετάστηκαν η κυτταροτοξική 
και κυτταροστατική επίδραση των ΑΖ και ΛΖ σε καλλιέργειες φυσιολογικών ανθρώπινων λεμφοκυτάρων περιφερικού αί-
ματος, σε τελικές συγκεντρώσεις (0.16-3.84 μM για την AZ και 0.62-3.72 μΜ για τη ΛZ) , οι οποίες είναι ισοδύναμες των 
δόσεων που χορηγούνται από του στόματος (για την AZ 0.25-6 mg/μέρα και για τη ΛZ 1-6 mg/μέρα). Έγινε εκτίμηση δύο 
παραμέτρων, των SCEs (χρωματιδιακές ανταλλαγές-sister chromaitid exchanges), μιας από τις πιο ευαίσθητες μεθόδους που 
αντανακλούν αστάθεια του DNA ή ελαττωματικό μηχανισμό επιδιόρθωσής του, και του PRI (δείκτης ρυθμού πολλαπλα-
σιασμού-proliferation rate index), ενός αξιόπιστου δείκτη κυτταροστατικής δράσης. Tόσο η ΑΖ όσο και η ΛΖ προκάλεσαν 
δοσοεξαρτώμενη, στατιστικά σημαντική αύξηση της συχνότητας των SCEs (p < 0.001), η οποία συνοδεύτηκε από στατιστικά 
σημαντική μείωση του PRI (p < 0.001) των λεμφοκυττάρων στις καλλιέργειες μετά από επώαση 72 ωρών. Τα αποτελέσματά 
μας υποδεικνύουν ότι οι ΑΖ και ΛΖ σε συγκεντρώσεις ισοδύναμες με τις χορηγούμενες από του στόματος δόσεις προκαλούν 
στατιστικά σημαντική γονοτοξικότητα σε καλλιέργειες φυσιολογικών ανθρώπινων λεμφοκυττάρων. 
Λέξεις Κλειδιά: Βενζοδιαζεπίνες, Λοραζεπάμη, Αλπραζολάμη, Χρωματιδιακές ανταλλαγές, Δείκτης ρυθμού πολλαπλασιασμού, 
Κυτταρογενετική δράση.
In vitro γονοτοξικότητα δύο ευρέως χρησιμοποιουμένων βενζοδιαζεπινών,  
της αλπραζολάμης και της λοραζεπάμης
Ζαφειρούλα Ιακωβίδου-Κρίτση, Κυριακή Ακριτοπούλου,  
Μαρία Θ. Οικονομοπούλου, Διονύσιος Μουρελάτος
Εργαστήριο Γενικής Βιολογίας και Γενετικής, Ιατρική Σχολή, Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης, Ελλάδα
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